Back to School: How biopharma can reboot drug development. Access exclusive analysis here

MGCD0103: Interim Phase II data

MethylGene Inc. (TSX:MYG), Montreal, Quebec
Pharmion Corp. (PHRM), Boulder, Colo.
Taiho Pharmaceutical Co. Ltd., Tokyo,

Read the full 171 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE